About ESPERVITA THERAPEUTICS, INC
Espervita Therapeutics is focused on the discovery of metabolic reprogramming therapies, with a lead program developing first-in-class acetyl-CoA metabolic enzyme inhibitors for metabolic diseases. The company is led by a team with deep expertise in metabolic dysfunction and drug discovery.
Is this your company?
Claim ESPERVITA THERAPEUTICS, INC to unlock the federal & state contracts GovIntel's AI has matched to you right now — plus your own scored past-performance, who you're up against, and who's risky to team with.
Claim ESPERVITA THERAPEUTICS, INC & see your matchesFree to claim. Takes about a minute.
Data compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate, or want this page removed? Request a correction or removal.